First24 Health Systems
Occupational Health · Workforce Continuity

Respiratory season is an operations problem.

The missing operational layer between exposure and illness.

The First24 Interceptive Protocol™ gives frontline organizations a structured, voluntary early-response workflow—and a measurable pilot for evaluating lost-duty days, overtime, and coverage disruption.

Get the Pilot BriefSee How the Protocol Works

Event-triggered. Episodic. Voluntary. Aggregate-only. Designed for medical, safety, legal, privacy, and labor review.

Illustrative pilot dashboard
Metro Transit — Bus Ops Division
Pilot Active
Active operating units
6
stations / shifts
Active exposure windows
2
cluster-triggered
Aggregate participation
—
voluntary opt-in
Lost-duty baseline
1,180
prev season
Governance reviewMedical · OH · Legal · Labor · complete
Values shown are illustrative and do not represent a real deployment or client outcome.
Voluntary participation
No employee mandate or employment consequence for declining.
Aggregate-only reporting
No individual medical information retained by First24.
Medical-governance ready
Designed to operate through organizational medical and occupational-health review.
Measured against your baseline
Operational outcomes evaluated using agreed organizational metrics.
The operational problem

One respiratory absence rarely costs only one shift.

For frontline organizations, respiratory illness can produce overtime, backfill requirements, coverage gaps, delayed service, reduced readiness, and concurrent staffing pressure.

01

Absences cascade

One missed shift can trigger overtime, reassignment, backfill, supervisory burden, and reduced operating flexibility.

02

Respiratory season clusters

Concurrent illness places pressure on staffing models built around isolated absences.

03

Frontline work concentrates exposure

Close-contact, enclosed, public-facing, and shift-based settings can create repeated exposure opportunities.

04

Most responses begin after disruption

By the time symptoms develop, staffing disruption may already be underway.

Operational cascade
Exposure
→
Early-response opportunity
→
Symptoms
→
Lost duty
→
Overtime, backfill, coverage disruption
The missing middle

The missing middle in respiratory readiness.

Workplace respiratory programs are usually organized around reducing exposure before it occurs and managing illness after symptoms become established. First24 structures the interval between those endpoints.

Before

Prevention

Before exposure

Reduce risk through established protections such as vaccination, cleaner air, PPE, respiratory protection, and hygiene.

Interval

Interception

Only after a Qualifying Exposure Event

Activate a predefined, voluntary, time-bounded early-response workflow — episodic, not daily. Ends when the exposure window closes.

After

Treatment & recovery

Established illness

Use testing, absence procedures, clinical evaluation, and medically appropriate care.

First24 does not replace prevention or treatment. It adds operational structure to the interval workplace programs often leave undefined.

“First24 turns an undefined interval into a governed operational workflow.”
Behavioral design

Built on the implementation logic that made hand hygiene teachable.

First24 translates an organization-approved respiratory-readiness protocol into a cue-based, brief and standardized workflow people can follow under real-world time pressure.

Operational implementation analogy only. First24 does not claim equivalent clinical evidence, regulatory status, biological mechanism or effect to handwashing.

The First24 Adherence Recipe

The protocol is designed to reduce decision friction at the moment action becomes relevant.

First24
STEP 01
An approved trigger may have occurred.
Review the trigger
Not now

Illustrative workflow. Content is set by the organization's approved protocol.

AI-assisted. Human-governed.

AI-assisted protocol architecture, controlled by human governance.

AI-assisted design was used to simplify sequencing, reduce decision friction and create a consistent trigger-to-action experience. Medical, occupational-health, safety, legal and organizational leaders retain control of the protocol's content and boundaries.

AI assists with
  • Workflow sequencing
  • Plain-language presentation
  • Consistent decision pathways
  • Reminder logic
  • Usability and implementation design
Humans govern
  • Exposure and symptom triggers
  • Eligibility and exclusions
  • Product and formulation review
  • Contraindications and instructions
  • Timing and frequency
  • Escalation and adverse-event procedures

Why the model is familiar

First24 borrows implementation principles used by established hygiene programs and translates them into a governed early-response workflow.

Right moment
Hygiene principle. Action linked to a recognizable moment.
First24 translation. An organization-approved trigger opens the workflow.
Point-of-need access
Hygiene principle. The action is available where and when it is needed.
First24 translation. Approved instructions are immediately available through the organization's workflow.
Standardized training
Hygiene principle. People learn one clear, repeatable process.
First24 translation. Concise training and consistent language are established before respiratory season.
Reminders and feedback
Hygiene principle. Timely prompts and measurement reinforce execution.
First24 translation. Bounded reminders and aggregate pilot measures support implementation review.
Safety culture
Hygiene principle. The organization supports the behavior through leadership and governance.
First24 translation. Participation is voluntary, non-retaliatory, medically governed and integrated with existing protections.

The comparison concerns implementation design only—not medical equivalence.

The breakthrough is not asking people to remember more.

It is giving them a clear cue, one approved action and a defined stopping point.

Recognize
→
Act
→
Confirm
→
Reinforce if active
→
Stop or escalate
The First24 Exposure Trigger Framework™

Not every exposure is the same.

First24 activates after recognizable events — not ordinary background contact. Most daily contact does not call for protocol activation. First24 uses a predefined exposure framework to distinguish ordinary background activity from recognizable events that may justify an early-response workflow.

"Not every exposure becomes an infection. Not every exposure warrants activation. First24 begins when a recognizable event crosses a predefined exposure threshold."

Activated by an event. Repeated only while the event remains active. Stopped when the exposure window closes.

A household illness

Repeated close contact with a household member who develops a respiratory illness may create an ongoing exposure window rather than a single exposure moment.

An event moving through the workforce

Multiple linked illnesses within one team, shift, station, department, or facility may meet the organization's cluster threshold.

A defined travel or event exposure

Long flights, group transportation, conferences, and crowded indoor events may qualify when duration, density, proximity, ventilation, known illness, or subsequent outbreak information meets the approved threshold.

A known close-contact event

Direct, prolonged, or repeated interaction with a symptomatic or subsequently confirmed individual may meet the organization's approved activation criteria.

An approved early-symptom trigger

The first organization-approved localized upper-respiratory indicators may activate the symptom-based pathway, including appropriate monitoring and escalation.

Qualifying Exposure Event. An organization-defined circumstance that creates a materially elevated likelihood of respiratory exposure compared with ordinary background activity and meets the trigger criteria established in the approved occupational-health protocol. Final triggers, exclusions, duration, cadence, and escalation criteria are established by the participating organization's medical and occupational-health leadership.

Exposure tiers

A three-tier framework distinguishes background contact from qualifying events.

Tier 0

Background contact

Ordinary daily interactions without a recognized elevated-risk event.

First24 status
No protocol activation.
Examples
  • Brief passing contact
  • Routine uncrowded workplace activity
  • Short public interaction with no known illness
  • Outdoor contact without additional identified risk factors
Tier 1

Elevated exposure setting

A setting involving one or more organization-defined risk modifiers, but without a confirmed or high-confidence source event.

First24 status
Apply organization-approved criteria. The setting alone does not automatically activate the protocol.
Examples
  • Prolonged enclosed travel
  • Crowded indoor gathering
  • Conference or large event
  • Repeated public-facing work
  • Elevated respiratory activity in the community
  • Shared transportation
  • Poorly ventilated or densely occupied environment
Tier 2

Qualifying exposure event

A recognized event meeting the organization's approved activation threshold.

First24 status
The voluntary Interceptive Protocol becomes available.
Examples
  • A symptomatic or test-confirmed household member
  • Multiple linked respiratory illnesses within one team, shift, station, or facility
  • Known prolonged close contact with a symptomatic or subsequently confirmed individual
  • Prolonged enclosed travel followed by a credible illness notification or cluster
  • Earliest organization-approved localized upper-respiratory symptoms
  • Another high-confidence event defined by the organization

Exposure does not mean infection. The framework standardizes when an optional workflow becomes available; it does not diagnose exposure, infection, or illness.

Interactive

Would this activate First24?

Explore how an organization-defined trigger framework could classify common situations.

01An employee briefly passes someone in a hallway.
+
Tier 0

Generally no activation — ordinary background contact.

Illustrative only. Final triggers are established by the participating organization's medical and occupational-health leadership.

02An employee takes a short, uncrowded trip with no known illness.
+
Tier 0/1

Generally no activation — absent additional organization-defined risk factors.

Illustrative only. Final triggers are established by the participating organization's medical and occupational-health leadership.

03An employee completes a prolonged, crowded flight and later receives a credible nearby-illness notification.
+
Tier 1 → 2

Potential qualifying event — apply the approved duration, proximity, density, ventilation, and notification criteria.

Illustrative only. Final triggers are established by the participating organization's medical and occupational-health leadership.

04A household member develops respiratory symptoms.
+
Tier 2

Likely qualifying event — repeated close contact may create an Active Exposure Window.

Illustrative only. Final triggers are established by the participating organization's medical and occupational-health leadership.

05Several employees from one shift report respiratory illness within a defined period.
+
Tier 2

Likely qualifying event — apply the organization's workplace-cluster threshold.

Illustrative only. Final triggers are established by the participating organization's medical and occupational-health leadership.

06An employee notices the first approved localized upper-respiratory symptoms.
+
Tier 2

Potential symptom-based trigger — activate only according to the approved protocol and escalation process.

Illustrative only. Final triggers are established by the participating organization's medical and occupational-health leadership.

This tool does not collect personal health information.

The Active Exposure Window™

One event does not always mean one moment of exposure.

An Active Exposure Window is the bounded period during which the qualifying exposure remains ongoing or the organization's approved follow-up criteria remain satisfied.

A household illness can create repeated close contact. A workplace cluster can continue across several shifts. A travel event can extend across an outbound journey, shared accommodations, meetings, and the return journey.

When a qualifying exposure remains active, the approved workflow may continue on a simple 24-hour operational cadence for the duration defined by the organization's protocol.

No qualifying trigger, no activation. No continuing exposure window, no continuing routine.

Medical-cadence limitation

The approved protocol may permit one routine within each 24-hour operational interval while a qualifying exposure window remains active. Exact formulation, route, frequency, duration, eligibility, contraindications, and administration instructions are determined through the participating organization's medical, product, regulatory, and occupational-health review. This website does not provide dosing, administration technique, or self-treatment instructions.

Operational workflow illustration — not a biological timeline
1
Qualifying event identified
2
Voluntary activation available
3
24-hour operational interval
4
Exposure still active?
YES → Next approved interval
NO → Routine ends
Monitor and escalate when indicated
Selective activation

Event-triggered by design — not indiscriminate daily use.

Not the First24 model

Indiscriminate daily program

  • ✕Used regardless of exposure
  • ✕Higher employee burden
  • ✕Difficult to sustain
  • ✕Weak connection between event and action
  • ✕Greater product and compliance complexity
The First24 model

Event-triggered workflow

  • ✓Activated by defined circumstances
  • ✓Episodic rather than continuous
  • ✓Clear start and stop
  • ✓Low-frequency participation
  • ✓Easier internal governance
  • ✓Easier implementation measurement
  • ✓Stronger connection between trigger and action

The comparison is framed around workflow, adoption, and governance — not medical superiority.

Recognize the event. Open the response window. Close it when the exposure ends.

Why First24

Why First24

First24 represents the principle that an early response should be operationally available. It is not a claim that every respiratory pathogen follows a universal 24-hour biological clock. The applicable trigger, timing, frequency, eligibility criteria, contraindications, and escalation procedures remain part of the organization's approved protocol.

Early-response window (illustrative)
Qualifying eventApproved response windowEstablished illness

Timing parameters are defined by the organization's approved protocol and are not presented as a universal biological deadline.

Continuity cost calculator

What does respiratory-season disruption cost your operation?

500
3.5
$420
1.50×
$85
Illustrative annual exposure
$1,251,250
Direct lost-duty exposure$735,000
Overtime & backfill exposure$367,500
Operational disruption exposure$148,750
Planning scenarios
5% improvement
$62,563
10% improvement
$125,125
15% improvement
$187,688
Suggested pilot cohort
75–175 participants

This calculator provides illustrative planning scenarios. It does not predict or guarantee First24 outcomes.

Receive a Pilot Model for Your Workforce
The category

A protocol that activates when the event warrants it.

First24 is not a permanent daily routine. It becomes available after a recognizable, organization-approved Qualifying Exposure Event and ends when the defined exposure window closes. Activated by an event. Repeated only while the event remains active. Stopped when the exposure window closes.

Event-triggered

Designed for defined exposure events or early localized symptoms rather than positioned as a permanent daily wellness routine.

Voluntary

Employees choose whether to participate, without pressure, retaliation, or employment consequence.

Standardized

Training, communications, eligibility criteria, contraindications, and escalation procedures are documented in advance.

Pathogen-independent workflow

The operational trigger does not require waiting for laboratory identification of a particular respiratory pathogen. Evidence may differ by organism and setting.

Medically governed

Product selection, timing, frequency, contraindications, instructions, and escalation remain subject to organizational medical review.

Layered

Designed to complement the organization's existing vaccination, ventilation, PPE, hygiene, testing, absence-management, and medical-care practices.

Program shape
Episodic vs. daily
Daily wellness program
No
Event-triggered occupational workflow
Yes

First24 is designed as an episodic protocol activated by defined circumstances. Exact use parameters are governed by the approved organizational protocol.

Protocol overview

Technical overview

  • Occupational health and respiratory readiness
  • Event-triggered workflow
  • Voluntary participation
  • Standardized training
  • Aggregate operational measurement
  • Organization-approved eligibility and escalation criteria
  • 0.5% PVP-I protocol subject to medical, product, regulatory, safety, and organizational review

The current protocol concept centers on the approved use of a 0.5% povidone-iodine formulation within an organization-governed respiratory-readiness workflow. Product selection, route, labeling, participant instructions, eligibility, contraindications, frequency, and timing must be approved through the applicable medical and regulatory review process.

How First24 works

A defined protocol. A controlled rollout. A measurable result.

Step 1

Define the trigger

The organization establishes approved exposure criteria, early-symptom triggers, eligible populations, contraindications, protocol boundaries, escalation procedures, and governance responsibilities.

Step 2

Train the team

Voluntary participants receive concise, standardized instructions through the organization's established occupational-health and safety structure.

Step 3

Measure the outcome

Aggregate respiratory-related absence, lost-duty, overtime, backfill, and coverage metrics are compared with an agreed baseline.

Step 4 (optional)

Review and decide

Medical, operational, safety, labor, and executive stakeholders review the results and determine whether a broader program is appropriate.

Early-response concept

Operationalizing early action.

01
Qualifying exposure
02
Approved protocol initiation
03
Routine monitoring
04
Escalation when indicated
05
Testing, absence, or medical care where appropriate

First24 is designed around prompt execution of a predefined protocol after an organization-defined qualifying exposure or at the earliest localized symptoms. The protocol does not require waiting for pathogen identification before activating an approved workflow.

First24 does not replace vaccination, ventilation, respiratory protection, hand hygiene, testing, staying home when ill, diagnosis, or medical care.

Timing is part of the protocol—not a promise of outcome.
Evidence

Evidence presented with its limits intact.

First24 organizes published research by evidence type so medical and occupational-health reviewers can distinguish laboratory findings, human clinical findings, and safety or tolerability observations.

Why timing is built into the workflow

Selected studies support a timing signal—not a universal success rate.

The research includes different interventions, populations and endpoints. Results must be presented in their own context rather than combined into one artificial percentage.

One trial. Same intervention. Different start.

Matsuyama et al. · Sci Rep 2022;12:20449
Japan randomized open-label trial · n=430 · PVP-I gargling
PCR-negative on Day 5
Higher is better.
Early start34.5%
Later start21.4%
Still infectious on Day 5
Lower is better.
Early start2.9%
Later start9.3%

Participants began PVP-I gargling from Day 2 or used water before switching to PVP-I after the Day-5 sampling. Earlier initiation was associated with greater reported viral clearance and lower remaining infectivity on Day 5.

Limitation. Open-label study in asymptomatic-to-mild COVID-19; no symptom difference was reported. The result does not establish a universal First24 outcome.

Supporting signal — not direct early-versus-late proof

Common-cold early-enrollment signal

12.6%
overall reported GSS benefit
39.7%
reported benefit in the ≤24-hour subgroup

Polasek and Friedland. Frontiers in Medicine. 2025.

Supporting signal — not direct early-versus-late proof

Early-treatment nitric-oxide trial

3 vs 7
median days to PCR-negative
82.8% vs 66.7%
PCR-negative by treatment end

Tandon et al. The Lancet Regional Health – Southeast Asia. 2022.

Evidence supports evaluation of a timely, governed workflow. It does not establish that the First24 program will prevent illness, reduce transmission or reduce absenteeism in every organization.

Request the Medical & OH Evidence Brief (PDF)Get the Pilot Brief

Choudhury et al. · 2021

Randomized clinical study
Indian Journal of Otolaryngology & Head & Neck Surgery

In the studied symptomatic COVID-19 population, the PVP-I group reported higher day-7 PCR negativity and differences in hospitalization and mortality compared with control.

Limitation.
Conducted in a specific symptomatic population; does not establish workforce prevention or post-exposure effectiveness.
Operational relevance.
Provides human clinical evidence from use initiated after illness was already present.

Kamal Arefin et al. · 2022

Randomized trial
European Archives of Oto-Rhino-Laryngology

PVP-I nasal spray or irrigation groups reported greater nasopharyngeal clearance than control under the studied conditions.

Limitation.
The studied population, protocol, delivery method, endpoints, and disease context may differ from a workforce-readiness program.
Operational relevance.
Supports further evaluation of 0.5% PVP-I protocols in defined settings.

Matsuyama et al. · 2022

Randomized trial
Scientific Reports

Earlier PVP-I gargling was associated with reported differences in salivary viral clearance and infectivity compared with delayed initiation.

Limitation.
Findings relate to the studied disease, oral protocol, timing, and population.
Operational relevance.
Supports the importance of protocol timing without establishing a universal post-exposure window.

Polasek et al. · 2025

Phase III RCT
Randomized, multicenter, double-blind, placebo-controlled Phase III trial — common-cold population
RandomizedDouble-blindPhase IIIn=260Post hoc early-start subgroup

A Phase III trial of 0.5% PVP-I nasal spray reported overall outcomes generally favoring the intervention. The prespecified primary nasal-symptom endpoint was not statistically significant in the full study population. A post hoc subgroup beginning treatment within 24 hours of symptom onset showed a reported 39.7% benefit in global symptom score compared with saline.

Limitation.
The early-start finding was a post hoc subgroup result based on symptom onset, not a known exposure event.
Operational relevance.
Supports evaluation of whether timing influences outcomes while requiring careful interpretation and further operational study.

Hassandarvish et al. · 2020

Early-phase study
Frontiers in Medicine

Reported viral-clearance findings in the studied cohort following a PVP-I protocol.

Limitation.
Early-phase evidence from a specific cohort and disease context.
Operational relevance.
Directionally relevant but not sufficient by itself to establish workforce-program efficacy.

What the evidence supports—and what it does not yet establish

Published research provides biological plausibility, laboratory activity, and clinical findings in specific populations and study conditions. It does not establish that the First24 workforce program will prevent illness or reduce absenteeism in every organization.

The purpose of a First24 pilot is to evaluate operational outcomes against an agreed organizational baseline under an approved governance structure.

Findings may vary by pathogen, formulation, route, timing, population, setting, and protocol.

First24 is intended to complement—not replace—vaccination, respiratory protection, cleaner air, testing, staying home when ill, or appropriate medical care.

Medical & Occupational-Health Evidence BriefPilot Governance Brief
Governance

Built to survive internal review.

The program is structured for the stakeholders who must approve, implement, and trust it.

Medical review

  • Protocol boundaries
  • Product and formulation review
  • Contraindications
  • Eligibility
  • Participant instructions
  • Timing and frequency
  • Escalation criteria
  • Adverse-event procedures

Occupational health & safety

  • Exposure triggers
  • Early-symptom triggers
  • Training
  • Workflow integration
  • Incident procedures
  • Existing infection-control alignment
  • Monitoring and escalation

Labor & HR

  • Voluntary opt-in participation
  • Non-retaliation
  • No employment consequence for declining
  • No supervisor pressure
  • Employee communication
  • Reasonable accommodation
  • Ability to discontinue
  • Appropriate leave & absence

Privacy & analytics

  • Aggregate reporting
  • Minimum-necessary data
  • No individual medical-data retention by First24
  • No individual outcome reporting to supervisors
  • Defined data access
  • Agreed retention rules
  • No medical information via website form

Optional by design. Governed against coercion.

Request the Governance Brief
Pilot

A measured pilot, sized to one operating unit.

Start with one team, facility, station, or shift group and evaluate the program using an agreed baseline and governance plan.

Scope

One defined workforce group, facility, station, team, or shift.

Participation

Voluntary and opt-in, using organization-approved communications and enrollment.

Implementation

Protocol design, implementation planning, training materials, workflow support, and aggregate reporting structure.

Measurement

Aggregate respiratory-related absence and lost-duty indicators, plus agreed operational measures such as overtime, backfill, schedule gaps, and continuity impact.

Governance

Medical, occupational-health, safety, legal, privacy, labor, and human-resources review as applicable.

Materials

Product selection, procurement, approval, storage, and distribution remain under the organization's established channels.

Baseline

Compared with a mutually agreed historical, matched, seasonal, or contemporaneous baseline, subject to available data.

Analysis

Results are interpreted as operational pilot findings, not as a controlled clinical-trial conclusion unless separately designed and approved as such.

Trigger-quality measures

The pilot evaluates trigger quality as well as operational outcomes.

Number of potential exposure events reported
Number meeting the approved qualifying threshold
Trigger category
Time from recognized event to voluntary protocol availability
Number of Active Exposure Windows
Average length of an Active Exposure Window
Aggregate voluntary participation
Implementation fidelity
Participant burden
Aggregate lost-duty days
Overtime and backfill
Coverage disruption
Escalations to testing, absence procedures, or medical care
False-trigger and missed-trigger review where measurable

The pilot assesses whether the trigger framework is understandable, selective, operationally manageable, and suitable for the organization — not merely whether participants complete the routine. First24 does not claim to determine whether an infection was caused by a particular exposure event.

Founding Partner Pilot

Selective fee waiver for qualified organizations

For a limited number of qualified organizations, First24 may waive its program-design and implementation fee. The participating organization retains control of procurement, medical approval, workforce participation, and internal governance.

Availability and scope are determined following a Pilot Fit Review. Procurement, internal review, and organization-specific costs remain under the participating organization's control.

See if Your Organization QualifiesDownload the Pilot Brief
Why First24 was created

Why First24 was created.

First24 began as a family respiratory-readiness practice used across an extended family of approximately 30 people over eight respiratory seasons. That experience motivated the founder to formalize a structured program for organizational evaluation.

Disclosure

This experience is observational and uncontrolled. It explains the program's origin and the founder's conviction; it is not presented as proof of efficacy.

About

Healthcare rigor applied to workforce continuity.

First24 Health Systems was founded by Paul Gathua, drawing on more than 21 years of experience in healthcare compliance and clinical auditing. The program applies the disciplines of protocol design, governance, documentation, implementation review, and measurable evaluation to respiratory-season workforce disruption.

FAQ

Frequently asked questions

Does every exposure activate First24?+

No. Most ordinary contact should not activate the protocol. Activation occurs only when an organization-defined circumstance meets the approved Qualifying Exposure Event threshold.

Does a qualifying exposure mean someone will become infected?+

No. Exposure does not mean infection. The framework establishes when an optional early-response workflow becomes available; it does not predict or diagnose infection.

Does every flight activate the protocol?+

No. Travel is evaluated using organization-approved factors such as duration, enclosure, density, proximity, ventilation, known illness, and credible subsequent notification.

What is an Active Exposure Window?+

It is the bounded period during which the qualifying exposure remains ongoing or approved follow-up criteria remain satisfied — for example, continuing household contact or a workplace cluster spanning multiple shifts.

Why might the workflow repeat during an exposure window?+

Some qualifying events involve repeated rather than single-point contact. Where medically approved, the workflow may permit one routine within each approved 24-hour operational interval while the exposure window remains active.

Who determines when the exposure window ends?+

The participating organization establishes the ending criteria through its approved medical and occupational-health protocol.

Is the protocol meant to be used every day?+

No. First24 is designed as an event-triggered, episodic workflow. Routine availability ends when the approved exposure-window criteria are no longer met.

Is participation voluntary?+

Yes. First24 is designed as an opt-in program. Declining participation should not create an employment consequence, retaliation, supervisor pressure, or loss of access to standard workplace protections.

Is First24 a medical treatment?+

First24 is positioned as an occupational-health and respiratory-readiness program under organizational evaluation. It does not diagnose, treat, cure, or guarantee prevention of respiratory disease. Product selection and protocol implementation remain subject to appropriate medical, regulatory, safety, legal, and organizational review.

Does First24 replace vaccination, PPE, ventilation, testing, or medical care?+

No. First24 is designed to complement established respiratory protections and medically appropriate care.

Why is it called First24?+

The name represents the principle that an early response should be operationally available. It does not mean every respiratory pathogen follows a universal 24-hour biological timeline.

Does the protocol require identifying the pathogen?+

The operational workflow is designed so an approved trigger need not depend on laboratory identification of a particular pathogen. Evidence and suitability may differ by organism, population, and setting.

Is First24 intended for daily use?+

The program is designed as an episodic, event-triggered workflow rather than a general daily wellness program. Exact timing and frequency remain part of the approved protocol.

Who approves the protocol?+

The participating organization determines the applicable approval process, which may include medical, occupational-health, safety, legal, privacy, labor, regulatory, and human-resources review.

Who procures the materials?+

Product selection and procurement remain under the organization's established clinical, safety, purchasing, and compliance channels.

What information does First24 collect?+

The pilot is designed around aggregate operational measurement. First24 does not request individual medical information through the website and should not provide individual health outcomes to supervisors.

How is pilot success measured?+

Measures are agreed before launch and may include aggregate respiratory-related absence, lost-duty days, overtime, backfill requirements, coverage gaps, participation, implementation fidelity, and other operational indicators.

Does First24 guarantee reduced absenteeism?+

No. Outcomes are evaluated through the pilot and are not guaranteed.

What workforce groups may be appropriate?+

Potential settings include frontline, public-facing, shift-based, close-contact, safety-sensitive, and operationally critical teams, subject to organizational review.

What happens after the pilot?+

Stakeholders review implementation, safety, participation, governance, operational outcomes, limitations, and whether further evaluation or broader use is appropriate.

Is the Founding Partner Pilot always free?+

No. For selected qualified organizations, First24 may waive its program-design and implementation fee. Procurement, internal review, and organization-specific costs remain under the participating organization's control.

Get the pilot brief

Start with an internal-ready pilot brief.

Tell us about your workforce. First24 will send a concise overview designed for operational, medical, occupational-health, safety, legal, privacy, and labor review.

Step 1 · Contact—Step 2 · Qualification (optional)
Get the Pilot Brief